#32: Understanding Translational Medicine: Benefits and Innovative ApproachesDay & Time:
June 23, 1:00PM - 4:30PMRoom Number:
160CDescription:Maximize your learning while attending the DIA 2013 49th Annual Meeting! Receive $100 off of your DIA 2013 meeting registration by registering for two half day tutorials or one full day tutorial. Purchases must be made at the same time in order to receive the discount.
The goal of translational medicine (TM) is to expedite the development of newly identified compounds to enhance the patient’s quality of life. Translational medicine is the synergy between epidemiology, basic research and clinical trials. In the recent past, TM has gained significant importance due to its promising role for accelerating research and development in academia and industry. Translational Medicine has great potential to enhance health care starting from prevention, diagnosis, and drug/device developments for clinical disorders. However, there are few clinician/scientists critically trained in translational research and more programs to foster their development are required. This tutorial will provide an overview of the translational medicine field including definitions and concepts, potential benefits as well as global initiatives and programs. This tutorial will help the professionals working at various positions in the pharma, biotech, medical device industries and academia to better understand translational medicine.
|#32: Understanding Translational Medicine||CME|
At the conclusion of this tutorial, attendees will be able to:
• Describe translational medicine definitions, concepts and potential benefits for industry and academia.
• Describe global translational medicine situations.Target Audience:
This tutorial is designed for professionals in the pharmaceutical, biotechnology and medical device fields to include:
- medical affairs personnel,
- medical directors,
- medical advisors,
- clinical investigators,
- clinical research associates,
- clinical trial leaders and managers, and
- clinician research physicians.